Company: APACU
Filing Date: 2025-08-01
Form Type: S-1/A
Source: 0001829126-25-005702
Chunk: 357

Company: StoneBridge Acquisition II Corp
Filing Date: 2025-08-01
Form: S-1/A
Chunk 357
---
 contained in Section 4(a)(2) of the Securities Act.

The number of founder shares outstanding was determined based on the expectation that the total size of this offering would be a maximum of 5,750,000 units if the underwriter’s over-allotment option is exercised in full and therefore that such founder shares would represent 25% of the outstanding shares after this offering. Up to 250,000 of the founder shares held by our sponsor will be surrendered for no consideration depending on the extent to which the underwriter’s over-allotment is exercised.

Each of our initial shareholders is an accredited investor for purposes of Rule 501 of Regulation D.

Our sponsor, the Maxim Individuals and the third party investors have agreed to purchase an aggregate of 150,000 private placement units ((or 153,750 private placement units if the underwriter’s over-allotment option is exercised in full)), at a price of $10.00 per unit, for an aggregate purchase price of $1,500,000 (or $1,537,500 if the underwriter’s over-allotment option is exercised in full), in a private placement that will close simultaneously with the closing of this offering. Of such 150,000 units (or 153,750 units if the underwriter’s over-allotment option is exercised in full), 65,000 units (or 68,750 units if the underwriter’s over-allotment option is exercised in full) will be purchased by our sponsor, 22,152 will be purchased by the Maxim Individuals (whether or not the underwriter’s option is exercised), and 62,848 units will be purchased by the third-party investors (whether or not the underwriter’s option is exercised). Each private placement unit will be identical to the units sold in this offering, except as described in this prospectus. The private placement units will be worthless if we do not complete our initial business combination. This issuance will be made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.

No underwriting discounts or commissions were paid or will be paid with respect to such sales.

<div align='center'>II-2</div>

| Item 16. | Exhibits and Financial Statement Schedules. |

Exhibit Index

| Exhibit No. |     | Description                                                                                                                                     |
| 1.1         |     | Form of Underwriting Agreement.                                                                                                                 |
| 3.1         |     | Memorandum and Articles of